7 result(s) for Adolescent and Young Adult (AYA)
| PI Name | Protocol # | Title |
|---|---|---|
| Christopher Ryan | IRB00009464 | A Phase II Study of Sorafenib with Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas |
| Sancy Leachman | IRB00010561 | War on Melanoma: Enlisting a cohort of melanoma survivors and their families |
| Brandon Hayes-Lattin | IRB00011894 | Protocol CCTL019B2206: A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial |
| Brandon Hayes-Lattin | IRB00011960 | Long Term Follow-Up of Patients Exposed to Lentiviral- Based CD19 directed CART Cell Therapy |
| Lara Davis | IRB00012039 | Sarcoma Survivorship Registry |
| Lara Davis | STUDY00015649 | A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma |
| Christopher Ryan | STUDY00016039 | [NCI CIRB] A Phase 2 Study of GPNMB-targeted Antibody-Drug Conjugate, CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE; IND# 128248, NSC# 763737), in Recurrent or Refractory Osteosarcoma |
You may also qualify for Phase 1 Program trials.